Severe acute respiratory syndrome (SARS): A year in review

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 357-381

  Skowronski, Danuta M ^a   Astell, Caroline ^b   Brunham, Robert C ^a   Low, Donald E ^c   Petric, Martin ^a   Roper, Rachel L ^d   Talbot, Pierre J ^e   Tam, Theresa ^f   Babiuk, Lorne ^g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d EAST CAROLINA UNIVERSITY   (United States)

^e INRS INSTITUT ARMAND FRAPPIER   (Canada)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Coronavirus; Emerging pathogen; Genomics; Pandemic; Zoonotic

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CONSENSUS INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN; INTERFERON; LOPINAVIR PLUS RITONAVIR; METHYLPREDNISOLONE; RIBAVIRIN; VIRUS VACCINE;

AVASCULAR NECROSIS; CHINA; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG MEGADOSE; EPIDEMIC; GENOME; HEMOLYSIS; HEMOLYTIC ANEMIA; HONG KONG; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION CONTROL; MYCOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; CORONAVIRUS; CORONAVIRUS INFECTIONS; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; PUBLIC HEALTH PRACTICE; RECURRENCE; RISK FACTORS; RNA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT OUTCOME; ZOONOSES;

EID: 14544304652     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.091103.134135     Document Type: Review

References (103)

1. World Health Organization. 2003. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). Rep. WHO/CDS/CSR/GAR/2003. 11
2. World Health Organization. 2003. Severe acute respiratory syndrome (SARS): report by the Secretariat. Rep. EB113/33
3. World Health Organization. 2004. Situation updates-SARS. http://www.who.int/csr/sars/archive/
4. Drosten C, Gunther S, Preiser W, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-76
5. Ksiazek TG, Erdman D, Goldsmith CS, et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med 348:1953-66
6. Fouchier RA, Kuiken T, Schutten M, et al. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423:240
7. Kuiken T, Fouchier RA, Schutten M, et al. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263-70
8. World Health Organization. 2004. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Communicable Disease Surveillance & Response (CSR). http://www.who.int/csr/sars/country/ table2004_04_21/en.
9. Lai MM, Holmes KV. 2001. Coronaviridae: the viruses and their replication. In Virology, ed. BN Fields, DM Knipe, PM Howley, et al., pp. 1163-85. Philadelphia: Lippincott Williams & Wilkins
10. Holmes KV. 2001. Coronaviruses. In Virology, ed. BN Fields, DM Knipe, PM Howley, et al., pp. 1187-1203. Philadelphia: Lippincott Williams & Wilkins
11. Sizun J, Soupre D, Legrand MC, et al. 1995. Neonatal nosocomial respiratory infection with coronavirus: a prospective study in a neonatal intensive care unit. Acta Paediatr. 84:617-20
12. Sizun J, Yu MW, Talbot PJ. 2000. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J. Hosp. Infect. 46:55-60
13. Van Der Hoek L, Pyrc K, Jebbink MF, et al. 2004. Identification of a new human coronavirus. Nat. Med. 10:368-73
14. Fouchier RA, Hartwig NG, Bestebroer TM, et al. 2004. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl. Acad. Sci. USA 101:6212-16
15. Zhong NS, Zheng BJ, Li YM, et al. 2003. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 362:1353-58
16. He JF, Xu RH, Yu DW, et al. 2003. Severe acute respiratory syndrome in Guangdong Province of China: epidemiology and control measures. Chin. J. Prev. Med. 37:227-32
17. Yu D, Li H, Xu R, et al. 2003. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders-Guangdong Province, China, 2003. Morb. Mortal. Wkly. Rep. 52:986-87
18. Guan Y, Zheng BJ, He YQ, et al. 2003. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302:276-78
19. Martina BE, Haagmans BL, Kuiken T, et al. 2003. Virology: SARS virus infection of cats and ferrets. Nature 425:915
20. Peiris JS, Yuen KY, Osterhaus AD, et al. 2003. The severe acute respiratory syndrome. N. Engl. J. Med. 349:2431-41
21. Zheng BJ, Guan Y, Wong KH, et al. 2004. SARS-related virus predating SARS outbreak, Hong Kong. Emerg. Infect. Dis. 10:176-78
22. St-Jean JR, Jacomy H, Desforges M, et al. 2004. Human respiratory coronavirus OC4s: genetic stability and neuroinvasion. J. Virol. 78:8824-34
23. Marra MA, Jones SJ, Astell CR, et al. 2003. The genome sequence of the SARS-associated coronavirus. Science 300: 1399-404
24. Rota PA, Oberste MS, Monroe SS, et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-99
25. Guo JP, Petric M, Campbell W, et al. 2004. SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 324:251
26. Chinese SARS Molecular Epidemiology Consortium. 2004. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303:1666-69
27. Rest JS, Mindell DP. 2003. SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting. Infect. Genet. Evol. 3:219-25
28. Snijder EJ, Bredenbeek PJ, Dobbe JC, et al. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331:991-1004
29. Poutanen SM, Low DE, Henry B, et al. 2003. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348:1995-2005
30. Lipsitch M, Cohen T, Cooper B, et al. 2003. Transmission dynamics and control of severe acute respiratory syndrome. Science 300:1966-70
31. Riley S, Fraser C, Donnelly CA, et al. 2003. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300:1961-66
32. Shen Z, Ning F, Zhou W, et al. 2004. Superspreading SARS events, Beijing, 2003. Emerg. Infect. Dis. 10:256-60
33. Dye C, Gay N. 2003. Modeling the SARS epidemic. Science 300:1884-85
34. Christian MD, Loutfy M, McDonald LC, et al. 2004. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg. Infect. Dis. 10:287-93
35. Wong TW, Lee CK, Tam W, et al. 2004. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg. Infect. Dis. 10:269-76
36. Peiris JS, Chu CM, Cheng VC, et al. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-72
37. Ng SKC. 2003. Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet 362:570-72
38. Yu IT, Li Y, Wong TW, et al. 2004. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J Med. 350:1731-39
39. Seto WH, Tsang D, Yung RW, et al. 2003. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361:1519-20
40. Varia M, Wilson S, Sarwal S, et al. 2003. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. Can. Med. Assoc. J. 169:285-92
41. Fisher DA, Lim TK, Lim YT, et al. 2003. Atypical presentations of SARS. Lancet 361:1740
42. Goh DL, Lee BW, Chia KS, et al. 2004. Secondary household transmission of SARS, Singapore. Emerg. Infect. Dis. 10:232-34
43. Health Canada, Population and Public Health Branch (PPHB). 2003. Health Canada summary of severe acute respiratory syndrome (SARS) cases: Canada and international, April 16, 2003. http://www.hc-sc.gc.ca/pphb-dgspsp/sars-sras/eu- ae/sars20030416_e.html
44. a. Monto AS. 1997. Coronaviruses. In Viral Infections of Humans: Epidemiology and Control, ed. AS Vans, RA Kaslow, pp. 211-27. New York: Plenum Medical Book Co.
45. Cheng VC, Hung IF, Tang BS, et al. 2004. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin. Infect. Dis. 38:467-75
46. Leung WK, To KF, Chan PK, et al. 2003. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125:1011-17
47. Lau KK, Yu WC, Chu CM, et al. 2004. Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis. 10:342-44
48. Ding Y, He L, Zhang Q, et al. 2004. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203:622-30
49. Tsui PT, Kwok ML, Yuen H, et al. 2003. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg. Infect. Dis. 9:1064-69
50. Nicolaou S, Al Nakshabandi NA, Muller NL. 2003. Images in clinical medicine. Radiologic manifestations of severe acute respiratory syndrome. N. Engl. J. Med. 348:2006
51. World Health Organization. 2003. Alert, verification and public health management of SARS in the post-outbreak period. Communicable Disease Surveillance & Response (CSR). http://www.who.int/csr/sars/postoutbreak/en/
52. World Health Organization. 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Communicable Disease Surveillance & Response (CSR). http://www.who.int/csr/sars/casedefinition/en/
53. Choi KW, Chau TN, Tsang O, et al. 2003. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann. Intern. Med. 139:715-23
54. Booth CM, Matukas LM, Tomlinson GA, et al. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 289:2801-9
55. Christian MD, Poutanen SM, Loutfy MR, et al. 2004. Severe acute respiratory syndrome. Clin. Infect. Dis. 38:1420-27
56. Wong KT, Antonio GE, Hui DS, et al. 2003. Thin-section CT of severe acute respiratory syndrome: evaluation of 74 patients exposed to or with the disease. Radiology 228:395-400
57. Li G, Zhao Z, Chen L, et al. 2003. Mild severe acute respiratory syndrome. Emerg. Infect. Dis. 9:1182-83
58. Hon K, Leung CW, Cheng W, et al. 2003. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 361:1701-3
59. rd Intersci. Conf. Antimicrobial Agents and Chemotherapy, Chicago, IL, Sep. 14-17. Program/Abstracts Addendum, p. 18 (Abstr. K-1315c)
60. Fowler RA, Lapinsky SE, Hallett D, et al. 2003. Critically ill patients with severe acute respiratory syndrome. JAMA 290:367-73
61. Lew TW, Kwek TK, Tai D, et al. 2003. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 290:374-80
62. Chan KS, Zheng JP, Mok YW, et al. 2003. SARS: prognosis, outcome and sequelae. Respirology 8(Suppl.):S36-S40
63. Bitnun A, Allen U, Heurter H, et al. 2003. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 112:e261
64. Wong RS, Wu A, To KF, et al. 2003. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326:1358-62
65. National Research Project for SARS Beijing Group, Wang C. 2003. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin. Med. J. (Engl.) 116: 1283-87
66. Lin M, Tseng HK, Trejaut JA, et al. 2003. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med. Genet. 4:9
67. Franks TJ, Chong PY, Chui P, et al. 2003. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34:743-48
68. Li G, Chen X, Xu A. 2003. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349:508-9
69. Shi Y, Yi Y, Li P, et al. 2003. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J. Clin. Microbiol. 41: 5781-82
70. Cui W, Fan Y, Wu W, et al. 2003. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin. Infect. Dis. 37:857-59
71. Li L, Wo J, Shao J, et al. 2003. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J. Clin. Virol. 28:239-44
72. Li W, Moore MJ, Vasilieva N, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-54
73. Hamming I, Timens W, Bulthuis M, et al. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203:631-37
74. Koren G, King S, Knowles S, et al. 2003. Ribavirin in the treatment of SARS: a new trick for an old drug? Can. Med. Assoc. J. 168:1289-92
75. Nicholls JM, Poon LL, Lee KC, et al. 2003. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361:1773-78
76. World Health Organization. 2004. Sampling for severe acute respiratory syndrome (SARS) diagnostic tests. Communicable Disease Surveillance & Response (CSR). http://www.who.int/csr/sars/sampling/en/
77. World Health Organization. 2003. WHO post-outbreak biosafety guidelines for handling of SARS-CoV specimens and cultures. Communicable Disease Surveillance & Response (CSR). http://www.who.int/csr/sars/biosafety2003- 12_18/en/
78. Lim PL, Kurup A, Gopalakrishna G, et al. 2004. Laboratory-acquired severe acute respiratory syndrome. N. Engl. J. Med. 350:1740-45
79. Ng EKO, Ng PC, Hon KL, et al. 2003. Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin. Chem. 49:2085-88
80. Poon LL, Chan KH, Wong OK, et al. 2004. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin. Chem. 50:67-72
81. Ng EK, Hui DS, Chan KC, et al. 2003. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin. Chem. 49:1976-80
82. Chan KH, Poon LL, Cheng VC, et al. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 10:294-99
83. Yam WC, Chan KH, Poon LL, et al. 2003. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J. Clin. Microbiol. 41:4521-24
84. Ng ML, Tan SH, See EE, et al. 2003. Proliferative growth of SARS coronavirus in Vero E6 cells. J. Gen. Virol. 84:3291-303
85. Wu HS, Chiu SC, Tseng TC, et al. 2004. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerg. Infect. Dis. 10:304-10
86. Tang P, Louie M, Richardson SE, et al. 2004. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. Can. Med. Assoc. J. 170:47-54
87. Cinatl J, Morgenstern B, Bauer G, et al. 2003. Treatment of SARS with human interferons. Lancet 362:293-94
88. Loutfy MR, Blatt LM, Siminovitch KA, et al. 2003. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290:3222-28
89. Zhao Z, Zhang F, Xu M, et al. 2003. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J. Med. Microbiol. 52:715-20
90. Hsu LY, Lee CC, Green JA, et al. 2003. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg. Infect. Dis. 9:713-17
91. Knowles SR, Phillips EJ, Dresser L, et al. 2003. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin. Infect. Dis. 37:1139-42
92. CDC SARS Investigative Team, Charles M. 2003. Severe acute respiratory syndrome (SARS) and coronavirus testing - United States, 2003. Morb. Mortal. Wkly. Rep. 52:297-302
93. Mazzulli T. 2004. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg. Infect. Dis. 10:20-24
94. Sung J. 2003. Clinical diagnosis and management of severe acute respiratory syndrome (SARS). Presented at WHO Global Conf. Severe Acute Respiratory Syndrome (SARS), Kuala Lumpur, Malaysia, June 17. http://www.who.int/csr/sars/conference/june_2003/materials/presentations/en/ clinical_diagnosis[1].pdf
95. Ho JC, Ooi GC, Mok TY, et al. 2003. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 168:1449-56
96. Oba Y. 2003. The use of corticosteroids in SARS. N. Engl. J. Med. 348:2034-35
97. Wang H, Ding Y, Li X, et al. 2003. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N. Engl. J. Med. 349:507-8
98. Johnson MA, Pooley C, Ignjatovic J, et al. 2003. A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus. Vaccine 21:2730-36
99. Weiss RC, Scott FW. 1981. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 4:175-89
100. Corapi WV, Olsen CW, Scott FW. 1992. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol. 66:6695-705
101. Olsen CW, Corapi WV, Ngichabe CK, et al. 1992. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J. Virol. 66:956-65
102. Yang Z-Y, Kong W-P, Huang Y, et al. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428:561-64
103. ter Meulen J, Bakker ABH, van den Brink E, et al. 2004. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363:2139-41